EFM
E Fund Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $278K | Sell |
16,057
-778
| -5% | -$13.5K | 0.01% | 323 |
|
|
2025
Q1 | $368K | Sell |
16,835
-327
| -2% | -$7.15K | 0.02% | 262 |
|
|
2024
Q4 | $548K | Buy |
17,162
+4,046
| +31% | +$129K | 0.03% | 216 |
|
|
2024
Q3 | $378K | Sell |
13,116
-1,580
| -11% | -$45.6K | 0.02% | 229 |
|
|
2024
Q2 | $564K | Buy |
14,696
+7,664
| +109% | +$294K | 0.03% | 166 |
|
|
2024
Q1 | $413K | Sell |
7,032
-625
| -8% | -$36.7K | 0.03% | 207 |
|
|
2023
Q4 | $458K | Sell |
7,657
-3,341
| -30% | -$200K | 0.03% | 177 |
|
|
2023
Q3 | $418K | Buy |
10,998
+6,035
| +122% | +$229K | 0.03% | 163 |
|
|
2023
Q2 | $452K | Sell |
4,963
-1,244
| -20% | -$113K | 0.04% | 127 |
|
|
2023
Q1 | $409K | Sell |
6,207
-2,397
| -28% | -$158K | 0.03% | 159 |
|
|
2022
Q4 | $445K | Buy |
8,604
+1,554
| +22% | +$80.4K | 0.04% | 155 |
|
|
2022
Q3 | $482K | Sell |
7,050
-3,601
| -34% | -$246K | 0.04% | 128 |
|
|
2022
Q2 | $482K | Buy |
10,651
+4,455
| +72% | +$202K | 0.04% | 147 |
|
|
2022
Q1 | $315K | Buy |
+6,196
| New | +$315K | 0.01% | 185 |
|